FTSE All-Share

FTSE All-Share handeln
5.628,78 PKT -14,66 PKT -0,26 %
finanzen.net zero
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

WKN 621441

ISIN GB0031758641


Analysen zu FTSE All-Share-Werten

Datum Rating Analyst
07.06.12 Tullow Oil hold Société Générale Group S.A. (SG)
07.06.12 Diageo hold ING
06.06.12 BP buy UBS AG
06.06.12 J. Sainsbury buy UBS AG
06.06.12 Imperial Brands buy UBS AG
06.06.12 BP neutral Citigroup Corp.
06.06.12 BP hold Société Générale Group S.A. (SG)
06.06.12 BP overweight J.P. Morgan Cazenove
05.06.12 Shell (ex Royal Dutch Shell) halten Independent Research GmbH
05.06.12 BP neutral Citigroup Corp.
05.06.12 AstraZeneca underperform Credit Suisse Group
05.06.12 GSK neutral Credit Suisse Group
05.06.12 Shell (ex Royal Dutch Shell) neutral Citigroup Corp.
04.06.12 Prudential outperform RBC Capital Markets
04.06.12 Diageo neutral Exane-BNP Paribas SA
04.06.12 AstraZeneca neutral Citigroup Corp.
04.06.12 GSK buy Citigroup Corp.
04.06.12 Shell (ex Royal Dutch Shell) buy Goldman Sachs Group Inc.
04.06.12 BP halten Independent Research GmbH
04.06.12 Glencore neutral Sarasin Research
04.06.12 Imperial Brands buy Société Générale Group S.A. (SG)
04.06.12 Kingfisher overweight HSBC
01.06.12 Glencore buy Société Générale Group S.A. (SG)
01.06.12 Kingfisher overweight J.P. Morgan Cazenove
01.06.12 Glencore neutral UBS AG
01.06.12 Kingfisher hold Société Générale Group S.A. (SG)
01.06.12 Prudential buy Société Générale Group S.A. (SG)
01.06.12 Antofagasta buy Nomura
01.06.12 Barclays outperform RBC Capital Markets
01.06.12 Vodafone Group outperform Sanford C. Bernstein and Co., Inc.
31.05.12 Barclays outperform Exane-BNP Paribas SA
31.05.12 HSBC outperform Exane-BNP Paribas SA
31.05.12 Kingfisher buy Sarasin Research
31.05.12 GSK buy UBS AG
31.05.12 BP overweight J.P. Morgan Cazenove
31.05.12 BT Group buy Nomura
30.05.12 AstraZeneca hold Deutsche Bank AG
30.05.12 GSK hold Deutsche Bank AG
30.05.12 Vodafone Group underperform Exane-BNP Paribas SA
30.05.12 Standard Chartered overweight J.P. Morgan Cazenove